Lund, Sweden

Sven Engstrom


Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 348(Granted Patents)


Location History:

  • Ume.ANG., SE (1994)
  • Lund, SE (1992 - 1998)

Company Filing History:


Years Active: 1992-1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Sven Engstrom: Innovator in Controlled-Release Preparations

Introduction

Sven Engstrom is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of controlled-release preparations, holding a total of 3 patents. His work focuses on developing methods and compositions that enhance the delivery of biologically active materials.

Latest Patents

Engstrom's latest patents include a method for preparing controlled-release preparations for biologically active materials. This method involves the formation of a mixture containing at least one amphiphilic substance capable of forming a liquid crystalline phase, in contact with a liquid selected from water, glycerol, ethylene glycol, propylene glycol, and their mixtures. Additionally, the method incorporates a step of providing a bioactive material within this mixture. Another significant patent is for a controlled-release composition for a biologically active material, wherein the active material is dissolved or dispersed in an L2-phase.

Career Highlights

Throughout his career, Sven Engstrom has worked with various companies, including Fluid-Carbon International AB and GS Development AB. His innovative approaches have led to advancements in the pharmaceutical and biotechnology sectors, particularly in drug delivery systems.

Collaborations

Engstrom has collaborated with notable colleagues such as Bjorn Lindman and Kare V Larsson. These partnerships have contributed to the development of his patented technologies and have fostered a collaborative environment for innovation.

Conclusion

Sven Engstrom's work in controlled-release preparations exemplifies the impact of innovative thinking in the field of biotechnology. His patents and collaborations highlight his commitment to advancing drug delivery systems, making significant strides in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…